Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink

•High variability in reimbursement across countries in radiation and surgical oncology.•Reimbursement should differentiate proven evidence-based interventions from emerging innovation.•Criteria for reimbursement of proven evidence should be based on episode of care.•For emerging innovation, coverage with evidence development should be considered.